Today's the Australian quote:
"Mesoblat has previously stated it has more than 1000 patents for many potential MSC applications in Australia, the US and Europe.
The company's chief executive, Silviu Itescu, has also claimed Mesoblast had the most mature cell therapy product pipeline and technology platform in the regenerative medicine industry.
He declined to comment yesterday on the Chinese study or Cantor Fitzgerald's assertion that it highlighted ' a new, upside opportunity for the company '...".
Prof is very cautious here for good reason!
DYOR!
Today's the Australian quote:"Mesoblat has previously stated it...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.020(1.82%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.21 | $1.07 | $23.44M | 20.68M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 72842 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 35009 | 7 |
View Market Depth
| Last trade - 12.41pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.08 |
Change
-0.020 ( 2.07 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.21 | $1.06 | 4309108 | ||
| Last updated 13.00pm 02/05/2024 ? | |||||
| MSB (ASX) Chart |